• español
    • English
    • português
  • English 
    • español
    • English
    • português
  • Login
View Item 
  •   Home
  • Productos de Investigación - Creación
  • Repositorio Documental COVID-19
  • Documentos científicos relacionados a la COVID-19
  • View Item
  •   Home
  • Productos de Investigación - Creación
  • Repositorio Documental COVID-19
  • Documentos científicos relacionados a la COVID-19
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
JavaScript esta deshabilitado en su navegador. Algunas características de este sitio no podrán funcionar o visualizarse correctamente sin JavaScript.
RecursosRecursos de apoyo¿Cómo publicar?

Browse

All of ExpeditioCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Statistics

View Usage StatisticsView Google Analytics Statistics
Estadísticas GTMVer Estadísticas GTM

Uneventful course in patients with inflammatory bowel disease during the severe acute respiratory syndrome coronavirus 2 outbreak in Northern Italy

Thumbnail

Citación

       
Export: <XML METS>
View/Open
Ver portada (189.2Kb)
Fin embargo: 
Artículo reservado (158.5Kb)
Fin embargo: 
Date
2020
Author
Norsa, Lorenzo
Indriolo, Amedeo
Sansotta, Naire
Cosimo, Paola
Greco, Salvatore
D’Antiga, Lorenzo
Metadata
Show full item record
Documentos PDF
Imagenes y Videos
Captura.PNG

Abstract
Since December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for coronavirus disease 2019 (COVID-19) has caused a pandemic, with more than 350,000 cases and more than 15,000 fatalities reported worldwide so far (https://www. healthmap.org/covid-19/). The first case series from the Wuhan population, describing the clinical characteristics of the SARS-CoV-2 infection in China, were recently published.1 However, further evidence is required to predict who is at higher risk of developing clinical symptoms. After the outbreak in China, the Lombardy region in Italy has become one of the areas with the highest incidence of new cases, and the outbreak is estimated to have begun on February 18, 2020. In particular, the province of Bergamo has reported, to date, 6471 positive results on nasopharyngeal swab for SARS-CoV-2 in a population of 1,114,590 inhabitants and is, therefore, the province with the highest rate of infection per 100,000 inhabitants worldwide2 (http:// www.salute.gov.it/portale/nuovocoronavirus/). A recent publication by the IBD Elite Union, which incorporates the 7 largest inflammatory bowel disease (IBD) referral centers in China, with more than 20,000 patients with IBD, reported no cases of COVID-19. This report included the 3 largest tertiary IBD centers in Wuhan (Tongji Hospital, Union Hospital, and Zhongnan Hospital) and was dated March 8.3 However, there is still uncertainty as to whether patients with IBD are more susceptible to COVID-19. To date, several strategies have been introduced in China to better manage patients with IBD during the Chinese outbreak of SARS-CoV2 (https://ecco-ibd.eu/images/6_Publication/6_8_Surveys/ 2nd_Interview_COVID-19_ECCO_Taskforce_published.pdf). The aim of this communication is to report the experience of our IBD center during the epidemic of SARS-CoV-2 in an area of high prevalence of the infection in Italy.
URI
http://hdl.handle.net/20.500.12010/11104
Link to resource
https://doi.org/10.1053/j.gastro.2020.03.062
Collections
  • Documentos científicos relacionados a la COVID-19 [2292]
Estadísticas Google Analytics
Comments

Respuesta Comentario Repositorio Expeditio

Gracias por tomarse el tiempo para darnos su opinión.


Carrera 4 # 22-61 Teléfono: (+57 1) 242 7030 - 018000111022 Fax: (+57 1) 561 2107 Bogotá D.C., Colombia

Fundación Universitaria de Bogotá Jorge Tadeo Lozano | Vigilada Mineducación

Institución de educación superior privada, de utilidad común, sin ánimo de lucro y su carácter académico es el de Universidad.

Reconocimiento personería jurídica: Resolución 2613 del 14 de agosto de 1959 Minjusticia.

Institución de Educación Superior sujeta a inspección y vigilancia por el Ministerio de Educación Nacional.

 

Términos y condiciones | Políticas

 

 


Carrera 4 # 22-61 Teléfono: (+57 1) 242 7030 - 018000111022 Fax: (+57 1) 561 2107 Bogotá D.C., Colombia

Fundación Universitaria de Bogotá Jorge Tadeo Lozano | Vigilada Mineducación

Institución de educación superior privada, de utilidad común, sin ánimo de lucro y su carácter académico es el de Universidad.

Reconocimiento personería jurídica: Resolución 2613 del 14 de agosto de 1959 Minjusticia.

Institución de Educación Superior sujeta a inspección y vigilancia por el Ministerio de Educación Nacional.

 

Términos y condiciones | Políticas